Anika T. Chowdhury

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Systematic Evaluation of Tyrosine Kinase Inhibitors as OATP1B1 Substrates Using a Competitive Counterflow Screen”.

Systematic Evaluation of Tyrosine Kinase Inhibitors as OATP1B1 Substrates Using a Competitive Counterflow Screen

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0332

N/A

0DataRank · unranked

9 citations

Mike Boeckman, Yan Yang, Kevin M. Huang, Peter de Bruijn, Mahesh R. Nepal +11 more

Drug–Drug Interaction Liabilities with BTK Inhibitor TL-895

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0265

N/A

0DataRank · unranked

1 citations

Eman Ahmed, Thomas Drabison, Mahesh R. Nepal, Anika T. Chowdhury, Shelley Orwick +6 more

Drug–drug interactions in targeted cancer therapies: a focus on tyrosine kinase inhibitors

Expert Review of Clinical Pharmacology(2025)10.1080/17512433.2025.2606258

N/A

0DataRank · unranked

0 citations

Anika T. Chowdhury, Kevin M. Huang, Shuiying Hu, Alex Sparreboom, Sharyn D. Baker +2 more